tiprankstipranks
Trending News
More News >
TScan Therapeutics (TCRX)
NASDAQ:TCRX
US Market

TScan Therapeutics (TCRX) Revenue

Compare
229 Followers

TScan Therapeutics Revenue

TScan Therapeutics had a revenue of 2.17M in the quarter ending Mar 31, 2025, with 226.47%. This bring the company's revenue in the last twelve months to 4.42M, Decreased 57.00%. In the fiscal year ending Dec 31, 2024, TScan Therapeutics had annual revenue of 2.82M with -86.62% growth.
Revenue (ttm)
4.42M
Revenue Growth
-70.15%
P/S Ratio
31.15
Revenue/Employee
$14,080
Employees
200
Market Cap
$87.72M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
2.82M-18.23M-86.62%
Dec 31, 2023
21.05M7.51M+55.52%
Dec 31, 2022
13.54M3.39M+33.47%
Dec 31, 2021
10.14M9.06M+834.65%
Dec 31, 2020
1.08M+∞%
Dec 31, 2019
0.00
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis